Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Lilly buys a near-billion dollars worth company and gets its prospective migraine drug back
January 18, 2017 Off

Lilly buys a near-billion dollars worth company and gets its prospective migraine drug back

By Dino Mustafić

Eli Lilly has bought a biotech company focusing on pain management, CoLucid Pharmaceuticals for approximately $960 million, ($46.50 per share)…

Moberg Pharma expands New Skin retail presence
January 18, 2017 Off

Moberg Pharma expands New Skin retail presence

By Dino Mustafić

Moberg Pharma’s New Skin Spray SKU will be sold in 3,900 Walmart stores and in over 1,500 Walgreens stores.

FDA OK’s Hikma’s US subsidiary’s narcolepsy drug
January 18, 2017 Off

FDA OK’s Hikma’s US subsidiary’s narcolepsy drug

By Dino Mustafić

Hikma Pharmaceuticals’s US subsidiary Roxane Laboratories has received an approval from the US Food and Drug Administration for its Sodium…

MDxHealth’s prostate cancer drug gets positive medical policy from Horizon BCBS
January 18, 2017 Off

MDxHealth’s prostate cancer drug gets positive medical policy from Horizon BCBS

By Dino Mustafić

Horizon Blue Cross Blue Shield (Horizon BCBS) of New Jersey has issued a positive medical policy for the MDxHealth’s ConfirmMDx for Prostate Cancer test.

Christina Wood joins OptiBiotix Health as Sales and Marketing Director
January 18, 2017 Off

Christina Wood joins OptiBiotix Health as Sales and Marketing Director

By Dino Mustafić

OptiBiotix Health, a life sciences business developing compounds to tackle obesity, highcholesterol, diabetes and skin care, has appointed Christina Wood as Sales and Marketing Director.

Galapagos appoints Chief Medical Officer
January 18, 2017 Off

Galapagos appoints Chief Medical Officer

By Dino Mustafić

Galapagos has appointed Dr. Walid Abi-Saab as a Chief Medical Officer (CMO), who came from Shire Pharmaceuticals, beginning on March 1, 2017.

January 18, 2017 Off

EC’s approval for Sanofi’s Suliqua triggers $10 million payment to Zealand Pharma

By Dino Mustafić

Zealand Pharma has announced a $10 million milestone payment following Sanofi’s announcement of European Commission marketing authorization in Europe for…

Motif Bio grantes 1,500,000 options to purchase ordinary shares
January 18, 2017 Off

Motif Bio grantes 1,500,000 options to purchase ordinary shares

By Dino Mustafić

Motif Bio, the clinical stage biopharmaceutical company specialising in developing novel antibiotics, has granted a total of 1,500,000 options to…

Ablynx issues additional common shares as result of warrant exercise
January 18, 2017 Off

Ablynx issues additional common shares as result of warrant exercise

By Dino Mustafić

Ablynx has issued additional 154,342 common shares in exchange for EUR1,011,939.05 as the result of the exercise of warrants.

Erytech to presents new preclinical data on ERY-MET at the 2017 ASCO GI Symposium
January 18, 2017 Off

Erytech to presents new preclinical data on ERY-MET at the 2017 ASCO GI Symposium

By Dino Mustafić

Erytech Pharma’s new data supporting the second company’s product candidate ERY-MET will be presented at the 2017 Gastrointestinal Cancers Symposium…

Posts pagination

Previous 1 … 3,524 3,525 3,526 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine